These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 29771235

  • 1. Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.
    Zomer A, Otsuka N, Hiramatsu Y, Kamachi K, Nishimura N, Ozaki T, Poolman J, Geurtsen J.
    Microb Genom; 2018 May; 4(5):. PubMed ID: 29771235
    [Abstract] [Full Text] [Related]

  • 2. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
    Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, McIntyre P, Marshall H, Guiso N, Keil AD, Lawrence A, Robson J, Hogg G, Lan R.
    Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.
    Pawloski LC, Queenan AM, Cassiday PK, Lynch AS, Harrison MJ, Shang W, Williams MM, Bowden KE, Burgos-Rivera B, Qin X, Messonnier N, Tondella ML.
    Clin Vaccine Immunol; 2014 Feb; 21(2):119-25. PubMed ID: 24256623
    [Abstract] [Full Text] [Related]

  • 4. Genome characteristics of Bordetella pertussis isolates from Tunisia.
    Ben Fraj I, Bouchez V, Smaoui H, Kechrid A, Brisse S.
    J Med Microbiol; 2019 Sep; 68(9):1320-1323. PubMed ID: 31329091
    [Abstract] [Full Text] [Related]

  • 5. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan.
    Kodama A, Kamachi K, Horiuchi Y, Konda T, Arakawa Y.
    J Clin Microbiol; 2004 Dec; 42(12):5453-7. PubMed ID: 15583264
    [Abstract] [Full Text] [Related]

  • 6. Genomic epidemiology of Iranian Bordetella pertussis: 50 years after the implementation of whole cell vaccine.
    Safarchi A, Octavia S, Nikbin VS, Lotfi MN, Zahraei SM, Tay CY, Lamichhane B, Shahcheraghi F, Lan R.
    Emerg Microbes Infect; 2019 Dec; 8(1):1416-1427. PubMed ID: 31543006
    [Abstract] [Full Text] [Related]

  • 7. Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis.
    Weigand MR, Pawloski LC, Peng Y, Ju H, Burroughs M, Cassiday PK, Davis JK, DuVall M, Johnson T, Juieng P, Knipe K, Loparev VN, Mathis MH, Rowe LA, Sheth M, Williams MM, Tondella ML.
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358336
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
    Xu Z, Octavia S, Luu LDW, Payne M, Timms V, Tay CY, Keil AD, Sintchenko V, Guiso N, Lan R.
    Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N, Guiso N.
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013.
    Quinlan T, Musser KA, Currenti SA, Zansky SM, Halse TA.
    Mol Cell Probes; 2014 Aug; 28(4):138-40. PubMed ID: 24365130
    [Abstract] [Full Text] [Related]

  • 16. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.
    Hegerle N, Dore G, Guiso N.
    Vaccine; 2014 Nov 20; 32(49):6597-600. PubMed ID: 25312274
    [Abstract] [Full Text] [Related]

  • 17. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.
    Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N.
    Vaccine; 2009 Oct 09; 27(43):6034-41. PubMed ID: 19666155
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan.
    Otsuka N, Han HJ, Toyoizumi-Ajisaka H, Nakamura Y, Arakawa Y, Shibayama K, Kamachi K.
    PLoS One; 2012 Oct 09; 7(2):e31985. PubMed ID: 22348138
    [Abstract] [Full Text] [Related]

  • 19. Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018.
    Mir-Cros A, Moreno-Mingorance A, Martín-Gómez MT, Abad R, Bloise I, Campins M, González-Praetorius A, Gutiérrez MN, Martín-González H, Muñoz-Almagro C, Orellana MÁ, de Pablos M, Roca-Grande J, Rodrigo C, Rodríguez ME, Uriona S, Vidal MJ, Pumarola T, Larrosa MN, González-López JJ.
    Emerg Infect Dis; 2022 May 09; 28(5):967-976. PubMed ID: 35447067
    [Abstract] [Full Text] [Related]

  • 20. [Molecular genetic characteristics of the B. pertussis strains isolated in different periods of the pertussis epidemic process].
    Mazurova IK, Borisova OIu, Kombarova SIu, Zakharova NS, Aleshkin VA.
    Mol Gen Mikrobiol Virusol; 2005 May 09; (4):21-5. PubMed ID: 16334221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.